U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, RECOMBINANT
Preferred Name English
BALORAMOTIDE
INN  
Official Name English
RECOMBINANT NY-ESO-1 PROTEIN
Common Name English
baloramotide [INN]
Common Name English
CANCER TESTIS ANTIGEN NY-ESO-1 (RECOMBINANT HUMAN)
Common Name English
CANCER/TESTIS ANTIGEN 1, RECOMBINANT
Common Name English
L ANTIGEN FAMILY MEMBER 2, RECOMBINANT
Common Name English
GLYCYL-L-PROLYL-HUMAN CANCER/TESTIS ANTIGEN 1 (AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, L ANTIGEN FAMILY MEMBER 2 (LAGE-2), CANCER/TESTIS ANTIGEN 6.1, CT6.1)
Common Name English
LAGE-2, RECOMBINANT
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 497815
Created by admin on Tue Apr 01 19:47:39 GMT 2025 , Edited by admin on Tue Apr 01 19:47:39 GMT 2025
NCI_THESAURUS C2835
Created by admin on Tue Apr 01 19:47:39 GMT 2025 , Edited by admin on Tue Apr 01 19:47:39 GMT 2025
Code System Code Type Description
FDA UNII
9T6PW6J6MA
Created by admin on Tue Apr 01 19:47:39 GMT 2025 , Edited by admin on Tue Apr 01 19:47:39 GMT 2025
PRIMARY
INN
10983
Created by admin on Tue Apr 01 19:47:39 GMT 2025 , Edited by admin on Tue Apr 01 19:47:39 GMT 2025
PRIMARY
SMS_ID
300000005886
Created by admin on Tue Apr 01 19:47:39 GMT 2025 , Edited by admin on Tue Apr 01 19:47:39 GMT 2025
PRIMARY
CAS
2207581-19-7
Created by admin on Tue Apr 01 19:47:39 GMT 2025 , Edited by admin on Tue Apr 01 19:47:39 GMT 2025
PRIMARY
NCI_THESAURUS
C38143
Created by admin on Tue Apr 01 19:47:39 GMT 2025 , Edited by admin on Tue Apr 01 19:47:39 GMT 2025
PRIMARY
ACTIVE MOIETY
BALORAMOTIDE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966